Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/4/14 → 9/30/20 |
Funding
- Children’s Hospital of Philadelphia
- Novartis Pharmaceuticals Corporation
Study Chair for COG AAML1321/Novartis CAMN107A2203: A multi-center, open label, non-controlled phase II study to evaluate efficacy and safety of oral nilotinib in pediatric patients with newly diagnosed Ph+ chronic myelogenous leukemia (CML) in chronic ph
- Hijiya, Nobuko (PD/PI)
Project: Research project